Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace)

The Lancet Infectious Diseases · Elsevier

Аннотация

Publication date: Available online 12 October 2026 Source: The Lancet Infectious Diseases Author(s): Marc Bonten, Christopher C Butler, Andrew Edwards, Stefan Gravenstein, Hiroshi Ikeda, Isik Somuncu Johansen, Merel M C Lambregts, Tetsuya Matsumoto, David L Paterson, Jesús Rodriguez-Baño, Elie Saade, Barry S Zingman, Tracey Day, Jeroen Geurtsen, Karin Hardt, Chelsea McLean, Ilse Scheys, Georgi Shukarev, Javier Ruiz Guiñazú, Michal Sarnecki

Читать у издателя →

Похожие статьи